Does TRILACICLIB Cause Performance status decreased? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Performance status decreased have been filed in association with TRILACICLIB (COSELA). This represents 6.2% of all adverse event reports for TRILACICLIB.
14
Reports of Performance status decreased with TRILACICLIB
6.2%
of all TRILACICLIB reports
0
Deaths
14
Hospitalizations
How Dangerous Is Performance status decreased From TRILACICLIB?
Of the 14 reports, 14 (100.0%) required hospitalization.
Is Performance status decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRILACICLIB. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does TRILACICLIB Cause?
Off label use (25)
Myelosuppression (24)
Dyspnoea (18)
Pneumonia (18)
White blood cell count decreased (18)
Platelet count decreased (17)
Anaemia (15)
Death (13)
Infection (12)
Haemorrhage (11)
What Other Drugs Cause Performance status decreased?
BACLOFEN (156)
LENALIDOMIDE (118)
PACLITAXEL (112)
BEVACIZUMAB (103)
SODIUM OXYBATE (103)
CARBOPLATIN (100)
DEXAMETHASONE (80)
CAPECITABINE (75)
NIRAPARIB (75)
LUMATEPERONE (68)
Which TRILACICLIB Alternatives Have Lower Performance status decreased Risk?
TRILACICLIB vs TRILEPTAL
TRILACICLIB vs TRIMEBUTINE
TRILACICLIB vs TRIMEPRAZINE
TRILACICLIB vs TRIMETAZIDINE
TRILACICLIB vs TRIMETHOBENZAMIDE